Stan Rockson

I’m proud to announce my Principal Investigator role on a 5-year ARPA-H funded project: Drug/Device Combinations to Prevent Cancer-Associated Lymphedema @arpahealth @stanford @lymphaticnetwork

@IsaacLeeLab @CornellBME @mchvdm Congratulations, Isak

Thrilled to announce I've received the NSF CAREER Award! This prestigious award will propel our research on cancer-related lymphedema forward. Immense gratitude to @CornellBME director @mchvdm, and our amazing faculty for their unwavering support! bme.cornell.edu/news/esak-lee-…

NHLBI helps launch the first NIH National Commission on Lymphatic Diseases! nhlbi.nih.gov/news/2024/nhlb…

Pleased to see our latest paper, "The Role of Inflammation in Lymphedema: A Narrative Review of Pathogenesis and Opportunities for Therapeutic Intervention", published in the International Journal of Molecular Science. @trasnochando mdpi.com/2736130

#OriginalResearch: Abnormal sphingosine-1-phosphate (S1P) signaling in lymphatic endothelial cells mediates pathogenic T cell activation, vascular insufficiency and lymphatic dysfunction @trasnochando @marknicolls ahajournals.org/doi/10.1161/CI…

It was such a pleasure to have Prof Rockson @StanfordMed @LymphaticNet as keynote speaker at #BLS2023 conference - inspiring as always! @BritishLymph @trasnochando

FINDING A DRUG FOR HUMAN LYMPHEDEMA: From Bedside to Bench to Bedside - a fantastic session from Professor Stanley Rockson. Thank you to Stanley for travelling from the States to deliver such great sessions. #BLS2023

@MCSneddon1 @StanfordMed @LymphaticNet @BritishLymph This was nut great honor - thank for the warm collegial welcome!

@IsaacLeeLab @CornellEng @CornellBME 🍾🍾🍾🍾🍾

Grateful and honored to receive the James and Mary Tien Excellence in Teaching Award, the highest award for teaching in the college! @CornellEng @IsaacLeeLab @CornellBME engineering.cornell.edu/news/awards-ho…

@CMJThompson Désolé Madame, il fera de son mieux, mais il n’a que 3 ans

At the beginning of our train journey Lausanne to Paris, a woman we didn’t know told Noah (aged 3) to keep quiet because she was very tired. How should I have reacted?

@lymphengineer so sorry I missed it and you

Great dinner last night with some of the Georgia Tech crew at the Lymphatic Forum in beautiful Banff.

@Ballinaleegirl Everything is going well. We are seeing response to drug! - but we cannot perform any analysis until all trial events are completed. Like you, we are very hopeful....🙏🏻🙏🏻🙏🏻

@trasnochando Hi Stanley can I ask how the Heal trial is doing? There are millions of us that are hoping so much it will be available soon. I do not live in the us and so cannot be in the trial, but I have longed for a treatment for many years . Yours hopefully

Today, we enrolled the first subject in the HEAL trial (Human Upper Extremity Acebilustat Lymphedema Trial). The study is intended to further investigate the ability of the specific LTB4 antagonist to reverse the structural damage in human chronic #lymphedema.

@CastorenaLab @nih_nhlbi Yes, see you there!

@CastorenaLab @nih_nhlbi Congratulations, Jorge!

@ChadSWeldy @American_Heart @RNAedit @StanfordDeptMed @StanCVFellows Congratulations!🍾🍾🍾

Thrilled to have found out I was awarded my @American_Heart Career Dev Award! Tremendous support from Tom Quertermous and Billy Li @RNAedit, @StanfordDeptMed @StanCVFellows. My work is focused on RNA editing and vascular disease -> genetics to epitranscriptome. So much to do!

@markkenney_3 @SchwarzLab_URMC @RocMSTP Congrats!

@lymphengineer Big props!!

science.org/doi/10.1126/sc… Excited to share this publication done with my long time collaborator and friend, Dr. Susan Thomas. We developed a strategy to deliver a calcium channel activator to lymphatic vessels to enhance their pumping and mitigate pump failure in a lymphedema model

Our paper - in collaboration with Professor Gianesini's laboratory and team - on the identification of the glycocalyx in the human #lymphatic vasculature is available on @ResearchGate: researchgate.net/publication/36…

@ShoaClarke Great points, Shoa! As a journal editor-in-chief, I can confirm the increasing unavailability of peer reviewers. I especially commend thr idea of recommending reviewers who are valid and likely to be receptive.

This is so frustrating and can be crippling to junior faculty careers. Putting aside the broken system, let's talk pragmatic strategy. What can early career folks do to help keep things moving in the quagmire? 5 tips 🧵

@IsaacLeeLab Congrats Esak

Good news! My article received enough citations to be a #topcitedarticle in its journal